Eli Lilly Issues Warning on Compounded Weight-Loss Drugs With Vitamin B12

In Brief

Eli Lilly has warned about health risks linked to compounded weight-loss drugs containing vitamin B12.

Key Facts

• Eli Lilly issued an urgent public warning regarding compounded weight-loss drugs.
• The warning concerns drugs containing vitamin B12.
• The alert relates to potential impurities in knockoff versions of weight-loss medications.

What Happened

Eli Lilly released an urgent warning about health risks associated with compounded weight-loss drugs containing vitamin B12, citing concerns over impurities in knockoff products.

Why It Matters

The warning highlights potential safety risks for individuals using compounded weight-loss drugs, especially those containing vitamin B12. It raises awareness about the quality and safety of non-original medications. Based on a single source report

What's Next

Consumers and healthcare providers may monitor for further guidance or regulatory action. Additional information from authorities or manufacturers could clarify the risks and recommended precautions.